| Over a month ago |
|
Recommendations
|
Barrington analysts… Barrington analysts announced their best ideas list for 2023: Blucora (BCOR), Carriage Services (CSV), CCC Intelligent Solutions (CCCS), ICF International (ICFI), Imax (IMAX), Insight Enterprises (NSIT), ModivCare (MODV), Outfront Media (OUT), Surmodics (SRDX) and WNS Holdings (WNS). ShowHide Related Items >><< - 12/16/22
- WNS Holdings acquires The Smart Cube, OptiBuy
- 11/17/22
- Surmodics reports 12-month data from SWING trial that met both primary endpoints
- 10/11/22
- Surmodics announces six-month data from SWING trial
- 09/19/22
- Outfront Media to replace Fossil in S&P 600 at open on 9/19
- 11/01/22
- ModivCare appoints L. Heath Sampson as CEO
- 08/02/22
- ModivCare CEO Greenleaf to leave company, Sampson named interim CEO
- 01/03/23
- Imax: 'Avatar: The Way of Water' ends 2022 as highest grossing release of year
- 12/27/22
- Imax crosses $100M in global box office with 'Avatar: The Way of Water'
- 12/19/22
- Imax announces 'Avatar: The Way of Water' delivers $48.8M opening weekend
- 12/12/22
- Imax names Manwaring as Chief Executive Officer
- 12/08/22
- ICF International awarded $25M U.S. Air Force contract
- 12/01/22
- ICF International awarded $26M recompete contract
- 11/21/22
- ICF International awarded over $45M in digital modernization contracts by HHS
- 11/02/22
- ICF International awarded $30M+ in contracts to support SAMHSA programs
- 12/12/22
- Carriage Services launches operating and financial plan for 2023 and 2024
- 10/27/22
- Carriage Services falls -21.2%
- 10/27/22
- Carriage Services falls -19.7%
- 10/25/22
- Carriage Services acquires Heritage Funeral and Forest Lawn East Cemetery
- 11/08/22
- Blucora announces year-to-date newly recruited assets of $1.3B
- 11/01/22
- Blucora to sell TaxAct for $720M, rebrand to Avantax
- 09/27/22
- Topel Forman affiliates with Avantax Planning Partners
- 08/29/22
- Avantax launches Women's Advisor Forum
- 11/01/22 Barrington
- Blucora price target raised to $30 from $25 at Barrington
- 07/11/22 Cantor Fitzgerald
- Blucora initiated with an Overweight at Cantor Fitzgerald
- 07/11/22 Cantor Fitzgerald
- Blucora initiated with an Overweight at Cantor Fitzgerald
- 06/27/22 Benchmark
- Blucora 'a most interesting,' under-the-radar idea, says Benchmark
- 10/27/22 Barrington
- Carriage Services price target lowered to $40 from $50 at Barrington
- 10/07/22 Barrington
- Carriage Services price target lowered to $50 from $55 at Barrington
- 07/29/22 B. Riley
- Carriage Services price target lowered to $62 from $76 at B. Riley
- 07/28/22 Barrington
- Carriage Services price target lowered to $55 from $65 at Barrington
CCCS CCC Intelligent Solutions - 11/01/22 Citi
- CCC Intelligent Solutions price target lowered to $10 from $11 at Citi
- 10/21/22 Barclays
- CCC Intelligent Solutions initiated with an Equal Weight at Barclays
- 08/08/22 Piper Sandler
- CCC Intelligent Solutions initiated with a Neutral at Piper Sandler
- 07/13/22 Goldman Sachs
- CCC Intelligent Solutions upgraded to Buy from Neutral at Goldman Sachs
- 08/29/22 Barrington
- ICF International price target raised to $129 from $121 at Barrington
- 08/04/22 Canaccord
- ICF International price target raised to $135 from $123 at Canaccord
- 06/13/22 Barrington
- ICF International price target raised to $121 from $118 at Barrington
- 01/11/22 Truist
- ICF International price target raised to $135 from $125 at Truist
- 12/05/22 B. Riley
- Imax price target raised to $23 from $20 at B. Riley
- 11/11/22 Wedbush
- Imax added to Best Ideas List at Wedbush
- 11/01/22 JPMorgan
- Imax price target lowered to $16 from $18 at JPMorgan
- 11/01/22 Wells Fargo
- Imax price target lowered to $21 from $26 at Wells Fargo
- 11/14/22 Barrington
- Insight Enterprises price target raised to $125 from $110 at Barrington
- 07/14/22 JPMorgan
- Insight Enterprises initiated with a Neutral at JPMorgan
- 01/03/22 Barrington
- Cars.com, Vizio among Barrington's 'Best Ideas' for 2002
- 01/03/23 Stephens
- Castle Biosciences, Academy Sports on Stephens 'Best Ideas' list for 2023
- 11/04/22 Barrington
- ModivCare price target lowered to $138 from $157 at Barrington
- 08/05/22 Barrington
- ModivCare price target raised to $157 from $155 at Barrington
- 08/02/22 Stephens
- ModivCare initiated with an Overweight at Stephens
- 08/12/22 Barrington
- Outfront Media price target lowered to $27 from $33 at Barrington
- 07/07/22 Citi
- Outfront Media price target lowered to $28 from $30 at Citi
- 06/10/22 Morgan Stanley
- Outfront Media price target lowered to $22 from $33 at Morgan Stanley
- 05/19/22 Citi
- Outfront Media price target lowered to $30 from $31 at Citi
- 12/15/22 JPMorgan
- WNS Holdings price target lowered to $102 from $109 at JPMorgan
- 12/07/22 Cowen
- WNS Holdings price target raised to $100 from $96 at Cowen
- 10/14/22 JPMorgan
- WNS Holdings price target lowered to $109 from $111 at JPMorgan
- 07/20/22 JPMorgan
- WNS Holdings price target lowered to $98 from $100 at JPMorgan
- 10/20/22
- WNS Holdings sees FY23 adjusted EPS $3.68-$3.87, consensus $3.73
- 10/20/22
- WNS Holdings reports Q2 adjusted EPS 93c, consensus 87c
- 07/21/22
- WNS Holdings raises FY23 adjusted EPS view to $3.62-$3.86 from $3.50-$3.73
- 07/21/22
- WNS Holdings reports Q1 adjusted EPS 90c, consensus 78c
- 11/09/22
- Surmodics reports Q4 EPS (26c), consensus (45c)
- 07/27/22
- Surmodics raises FY22 EPS view to ($1.50)-($1.35) from ($1.70)-($1.35)
- 07/27/22
- Surmodics reports Q3 EPS (34c), consensus (38c)
- 11/03/22
- Outfront Media reports Q3 EPS 23c, consensus 25c
- 08/03/22
- Outfront Media reports Q2 EPS 28c, consensus 24c
- 11/03/22
- Insight Enterprises sees FY22 EPS $8.65- $8.75 consensus $8.68
- 11/03/22
- Insight Enterprises reports Q3 EPS $1.99, consensus $1.93
- 08/04/22
- Insight Enterprises reports Q2 EPS $2.42, consensus $2.10
- 11/03/22
- ModivCare raises FY22 revenue view to $2.45B-$2.475B from $2.375B-$2.4B
- 11/03/22
- ModivCare reports Q3 adjusted EPS $1.61, consensus $1.62
- 08/04/22
- ModivCare raises FY22 revenue view to $2.375B-$2.4B from $2.35B-$2.375B
- 08/04/22
- ModivCare reports Q2 adjusted EPS $1.99 vs. $2.14 a year ago
- 10/31/22
- Imax reports Q3 adjusted EPS (5c), consensus 3c
- 07/28/22
- Imax reports Q2 adjusted EPS 7c, consensus 15c
- 08/03/22
- ICF International raises 2022 non-GAAP EPS view to $5.50-$5.80 from $5.15-$5.45
- 08/03/22
- ICF International reports Q2 non-GAAP EPS $1.33, consensus $1.31
- 12/12/22
- Carriage Services goal for FY24 EPS $2.95-$3.05
- 10/26/22
- Carriage Services reports Q3 EPS 45c, consensus 56c
- 07/27/22
- Carriage Services reports Q2 adjusted EPS 58c, consensus 82c
CCCS CCC Intelligent Solutions - 08/04/22
- CCC Intelligent Solutions sees Q3 revenue $194M-$196M, consensus $192.1M
- 08/04/22
- CCC Intelligent Solutions sees FY22 revenue $773M-$777M, consensus $768.9M
- 08/04/22
- CCC Intelligent Solutions reports Q2 EPS 2c, consensus 8c
- 11/01/22
- Blucora sees 2022 EPS $1.75-$1.84, consensus $1.83
- 11/01/22
- Blucora reports Q3 EPS (20c), consensus (16c)
- 08/08/22
- Blucora sees FY22 EPS $1.71-$1.90, consensus $1.83
- 08/08/22
- Blucora reports Q2 adjusted EPS 99c, consensus $1.04
|
|
Recommendations
|
Stephens analysts have… Stephens analysts have published their 2023 "Best Ideas" list, naming Knight-Swift (KNX), Casey's General Stores (CASY), Webster Financial (WBS), Black Knight (BKI), Castle Biosciences (CSTL), Crowdstrike (CRWD), ModivCare (MODV), Vulcan Materials (VMC), Academy Sports (ASO), Avid Bioservices (CDMO), Wendy's (WEN), Descartes Systems (DSGX), Old National Bancorp (ONB), Watsco (WSO), Flywire (FLYW), Stellar Bancorp (STEL), Glaukos (GKOS), First Foundation (FFWM) and Vizio (VZIO) to the list. As previously reported, the seven stocks that were carried over on the firm's "Best Ideas" list from 2022 included: Casey's General, Crowdstrike, Glaukos, Vizio, Vulcan Materials, Webster Financial and Wendy's. ShowHide Related Items >><< - 01/03/23
- Watsco board increases quarterly dividend to $2.45 per share
- 10/20/22
- Watsco raises annual dividend 11% to $9.80 per share
- 07/26/22
- Watsco boosts annualized technology spending to $48M
- 07/26/22
- Watsco expects North American HVAC/R demand trends will moderate
- 11/15/22
- Wendy's Central Florida restaurants sourcing renewable energy from Duke Energy
- 11/14/22
- Nelson Peltz's Trian boosts P&G, cuts Ferguson in Q3
- 11/09/22
- Wendy's reports Q3 U.S. same-restaurant sales growth 6.4%
- 11/09/22
- Wendy's reports Q3 U.S. systemwide sales growth of 7.7%
- 12/14/22
- Webster Financial raises prime lending rate to 7.5% from 7%, effective Dec. 15
- 12/05/22
- Webster Financial to acquire interLINK, terms not disclosed
- 11/17/22
- Webster Financial's HSA Bank to acquire accounts from Inland Bank and Trust
- 11/02/22
- Webster Financial raises prime lending rate to 7% from 6.25%, effective 11/ 3
- 10/20/22
- Vizio leverages SpringServe Tiles to enhance content discovery
- 10/19/22
- U.S. ITC institutes investigation of Vizio smart TVs at request of Maxell
- 10/06/22
- Vizio reports 100% increase in direct advertising commitments year-over-year
- 08/31/22
- Vizio announces addition of four free channels from E.W. Scripps to WatchFree+
- 10/03/22
- CBTX to replace Allegiance Bancshares in S&P 600 at open on 10/3
- 11/01/22
- ModivCare appoints L. Heath Sampson as CEO
- 08/02/22
- ModivCare CEO Greenleaf to leave company, Sampson named interim CEO
- 12/19/22
- Embark Technology provides first Embark-powered truck to Knight-Swift
- 10/19/22
- Knight-Swift sees overall consumer moderating in Q4
- 09/07/22
- Glaukos rises 19.5%
- 09/07/22
- Glaukos rises 12.2%
- 09/07/22
- Glaukos rises 7.6%
- 09/07/22
- Glaukos announces two iDose TR trials met primary endpoints
- 12/15/22
- Flywire releases ESG report
- 11/17/22
- Flywire partners with HDFC Bank to digitize payments from India
- 11/14/22
- Tiger Global takes stakes in Visa, Mastercard, exits position in Flywire
- 09/14/22
- Flywire partners with Universitas XXI to deliver integrated payment solution
- 11/21/22
- First Foundation announces CEO Scott Kavanaugh named president
- 11/08/22
- First Foundation says president DePillo to leave, CFO Thompson named interim
- 09/19/22
- ASRV selects Descartes' ecommerce warehouse, shipping solution
- 11/21/22
- Castle Biosciences gets ccreditation from College of American Pathology
- 11/15/22
- Castle Biosciences: DecisionDx -SCC test adds clarity in ambiguos situations
- 10/25/22
- Castle Biosciences announces new TissueCypher Barrett's Esophagus Test results
- 10/20/22
- Castle Biosciences announces new data from DECIDE study
- 12/29/22
- Crowdstrike director Austin buys $2.5M in company shares
- 12/01/22
- Crowdstrike CEO: Most companies would kill for our results
- 11/30/22
- Cathie Wood's ARK Investment bought 39.2K shares of Crowdstrike today
- 11/29/22
- Crowdstrike sees Q4 ARR below Q3 levels by up to 10%
- 11/16/22
- Avid Bioservices appoints Lukash as vice president, people
- 10/10/22
- Tomi to install custom engineered iHP System in Avid Bioservices facility
- 09/22/22
- Avid Bioservices appoints Alston as VP, operations
- 09/01/22
- Avid names Prem Patel as VP, process development, mammalian cell business
CASY Casey's General Stores - 12/06/22
- Casey's General Stores sees FY23 same-store inside sales 5%-7%.
- 09/07/22
- Casey's General Stores still sees FY23 SSS up 4%-6%
- 10/12/22
- Black Knight integrates Surefire, Servicing Digital solutions
- 09/07/22
- Black Knight's Optimal Blue adds ICE Mortgage Rate Lock to CompassPoint
- 07/24/22
- Fly Intel: Top five weekend stock stories
- 11/28/22 Deutsche Bank
- Knight-Swift price target raised to $69 from $63 at Deutsche Bank
- 10/20/22 Citi
- Knight-Swift price target lowered to $50 from $52 at Citi
- 10/20/22 KeyBanc
- Knight-Swift price target lowered to $60 from $70 at KeyBanc
- 08/22/22 Evercore ISI
- Evercore upgrades Schneider to Outperform on attractive risk/reward
CASY Casey's General Stores - 12/28/22 Stephens
- Stephens carries over seven stocks to 'Best Ideas' list for 2023
- 12/19/22 Credit Suisse
- Casey's General Stores initiated with a Neutral at Credit Suisse
- 12/08/22 Benchmark
- Casey's General Stores price target raised to $275 from $230 at Benchmark
- 12/08/22 Deutsche Bank
- Casey's General Stores price target raised to $291 from $286 at Deutsche Bank
- 12/13/22 JPMorgan
- Webster Financial price target lowered to $50 from $56 at JPMorgan
- 12/05/22 Morgan Stanley
- Webster Financial initiated with an Overweight at Morgan Stanley
- 11/28/22 Stephens
- Webster Financial named a 'Best Idea' at Stephens
- 12/06/22 Raymond James
- IntercontinentalExchange price target raised to $130 from $123 at Raymond James
- 12/02/22 Barclays
- Black Knight downgraded to Equal Weight from Overweight at Barclays
- 11/17/22 BofA
- IntercontinentalExchange upgraded to Buy from Neutral at BofA
- 05/20/22 Jefferies
- IntercontinentalExchange price target lowered to $134 from $161 at Jefferies
- 11/03/22 Baird
- Castle Biosciences price target lowered to $41 from $48 at Baird
- 08/09/22 Baird
- Castle Biosciences price target raised to $48 from $44 at Baird
- 05/19/22 Baird
- Baird says final LCD for test 'incrementally positive' for Castle Biosciences
- 05/10/22 Canaccord
- Castle Biosciences price target lowered to $65 from $80 at Canaccord
- 12/15/22 Wedbush
- Wedbush bullish on Crowdstrike, initiates with an Outperform
- 12/14/22 Wedbush
- Crowdstrike initiated with an Outperform at Wedbush
- 12/09/22 BTIG
- Datadog price target lowered to $93 from $104 at BTIG
- 11/04/22 Barrington
- ModivCare price target lowered to $138 from $157 at Barrington
- 08/05/22 Barrington
- ModivCare price target raised to $157 from $155 at Barrington
- 08/02/22 Stephens
- ModivCare initiated with an Overweight at Stephens
- 05/06/22 Deutsche Bank
- ModivCare price target lowered to $130 from $150 at Deutsche Bank
- 12/19/22 Stifel
- Vulcan Materials price target raised to $227 from $215 at Stifel
- 12/08/22 JPMorgan
- Vulcan Materials upgraded to Overweight from Neutral at JPMorgan
- 10/12/22 DA Davidson
- Vulcan Materials price target lowered to $200 from $205 at DA Davidson
- 12/14/22 Loop Capital
- Academy Sports price target raised to $65 from $60 at Loop Capital
- 12/08/22 UBS
- Academy Sports price target raised to $76 from $60 at UBS
- 12/08/22 Wedbush
- Academy Sports price target raised to $62 from $57 at Wedbush
- 12/08/22 Loop Capital
- Academy Sports price target raised to $65 from $60 at Loop Capital
- 12/07/22 Craig-Hallum
- Avid Bioservices price target lowered to $25 from $30 at Craig-Hallum
- 06/30/22 RBC Capital
- Avid Bioservices price target lowered to $22 from $32 at RBC Capital
- 03/09/22 Craig-Hallum
- Avid Bioservices price target lowered to $30 from $35 at Craig-Hallum
- 12/15/22 Jefferies
- Wendy's initiated with a Hold at Jefferies
- 11/10/22 Deutsche Bank
- Wendy's price target lowered to $23 from $24 at Deutsche Bank
- 11/10/22 Citi
- Wendy's price target lowered to $22 from $23 at Citi
- 12/08/22 BMO Capital
- Descartes Systems price target lowered to $71 from $74 at BMO Capital
- 12/08/22 Barclays
- Descartes Systems price target lowered to $58 from $60 at Barclays
- 11/17/22 Wolfe Research
- Wolfe reshuffles ratings in freight with five downgrades and one upgrade
- 11/17/22 Wolfe Research
- Descartes Systems downgraded to Peer Perform from Outperform at Wolfe Research
- 05/13/22 Stephens
- Stephens upgrades Old National Bancorp to Overweight after 'waiting patiently'
- 05/13/22 Stephens
- Old National Bancorp upgraded to Overweight from Equal Weight at Stephens
- 10/24/22 Deutsche Bank
- Watsco price target raised to $294 from $284 at Deutsche Bank
- 10/20/22 Deutsche Bank
- Watsco price target lowered to $284 from $311 at Deutsche Bank
- 10/12/22 Morgan Stanley
- Watsco price target raised to $218 from $217 at Morgan Stanley
- 09/06/22 KeyBanc
- Watsco price target raised to $310 from $300 at KeyBanc
- 10/24/22 Loop Capital
- Flywire initiated with a Buy at Loop Capital
- 09/22/22 Truist
- Flywire initiated with a Buy at Truist
- 07/14/22 Goldman Sachs
- Flywire upgraded to Buy from Neutral at Goldman Sachs
- 06/30/22 Raymond James
- Flywire added to 'Analyst Current Favorites' list at Raymond James
- 12/13/22 Stephens
- Stellar Bancorp upgraded to Overweight from Equal Weight at Stephens
- 10/06/22 Raymond James
- Stellar Bancorp assumed with an Outperform at Raymond James
- 12/28/22 Stephens
- Glaukos price target lowered to $68 from $69 at Stephens
- 12/28/22 Stephens
- Cutera price target lowered to $68 from $78 at Stephens
- 12/22/22 Mizuho
- Glaukos initiated with a Neutral at Mizuho
- 10/26/22 DA Davidson
- First Foundation downgraded to Neutral from Buy at DA Davidson
- 07/27/22 B. Riley
- First Foundation price target raised to $23 from $21 at B. Riley
- 07/11/22 B. Riley
- First Foundation downgraded to Neutral from Buy at B. Riley
- 04/12/22 B. Riley
- First Foundation price target lowered to $31 from $34 at B. Riley
- 12/23/22 Needham
- Vizio price target lowered to $11 from $16 at Needham
- 12/01/22 Morgan Stanley
- Vizio initiated with an Equal Weight at Morgan Stanley
- 10/04/22 Stephens
- Adeia initiated with an Overweight at Stephens
- 10/20/22
- Watsco reports Q3 EPS $4.03, consensus $4.35
- 07/26/22
- Watsco reports Q2 EPS $4.93, consensus $5.05
- 11/09/22
- Wendy's backs FY22 adjusted EPS view 84c-88c, consensus 85c
- 11/09/22
- Wendy's reports Q3 EPS 24c, consensus 23c
- 11/08/22
- Notable companies reporting before tomorrow's open
- 10/20/22
- Webster Financial reports Q3 adjusted EPS $1.46, consensus $1.41
- 07/21/22
- Webster Financial reports Q2 adjusted EPS $1.29, consensus $1.25
- 11/09/22
- Vizio sees Q4 adjusted EBITDA $15M-$19M
- 11/09/22
- Vizio reports Q3 EPS 1c, consensus 1c
- 08/10/22
- Vizio sees Q3 adjusted EBITDA $8M-$13M
- 08/10/22
- Vizio reports Q2 EPS 1c vs (8c) last year
- 11/02/22
- Vulcan Materials narrows FY22 adjusted EBITDA view to $1.64B-$1.68B
- 11/02/22
- Vulcan Materials reports Q3 adjusted EPS $1.78, consensus $1.70
- 09/29/22
- Vulcan Materials raises adjusted EBITDA target to $2.7B-$3B
- 08/04/22
- Vulcan Materials cuts FY22 adjusted EBITDA view to $1.6B-$1.7B from $1.72-$1.82B
- 10/28/22
- Stellar Bancorp reports Q3 EP 52c vs 59c last year
- 10/25/22
- Old National Bancorp reports Q3 adjusted EPS 51c, consensus 50c
- 07/26/22
- Old National Bancorp reports Q2 adjusted EPS 46c, consensus 39c
- 11/03/22
- ModivCare raises FY22 revenue view to $2.45B-$2.475B from $2.375B-$2.4B
- 11/03/22
- ModivCare reports Q3 adjusted EPS $1.61, consensus $1.62
- 08/04/22
- ModivCare raises FY22 revenue view to $2.375B-$2.4B from $2.35B-$2.375B
- 08/04/22
- ModivCare reports Q2 adjusted EPS $1.99 vs. $2.14 a year ago
- 10/19/22
- Knight-Swift cuts FY22 EPS view to $5.17-$5.22 from $5.30-$5.45 prior
- 10/19/22
- Knight-Swift reports Q3 adjusted EPS $1.27, consensus $1.32
- 07/20/22
- Knight-Swift raises FY22 adjusted EPS view to $5.30-$5.45 from $5.20-$5.40
- 07/20/22
- Knight-Swift reports Q2 adjusted EPS $1.41, consensus $1.35
- 11/02/22
- Glaukos narrows FY22 revenue view to $278M-$280M from $275M-$280M
- 11/02/22
- Glaukos reports Q3 adjusted EPS (45c), consensus (52c)
- 08/03/22
- Glaukos sees FY22 revenue $275M-$280M, consensus $274.4M
- 08/03/22
- Glaukos reports Q2 EPS (83c), consensus (44c)
- 11/08/22
- Flywire sees FY22 revenue $285.4M-$288.7M, consensus $274.41M
- 11/08/22
- Flywire sees Q4 revenue $69.3M-$72.6M, consensus $68.55M
- 11/08/22
- Flywire reports Q3 EPS (4c), may not compare to consensus 7c
- 08/09/22
- Flywire reports Q2 EPS (22c), consensus (14c)
- 10/25/22
- First Foundation reports Q3 EPS 51c, consensus 51c
- 07/26/22
- First Foundation reports Q2 EPS 59c, consensus 53c
- 12/07/22
- Descartes Systems reports Q3 EPS 31c, consensus 27c
- 09/07/22
- Descartes Systems reports Q2 EPS 27c, consensus 27c
- 11/02/22
- Castle Biosciences raises FY22 revenue view to $132M-$137M from $130M-$135M
- 11/02/22
- Castle Biosciences reports Q3 EPS (77c), consensus (88c)
- 09/20/22
- Castle Biosciences sees FY25 revenue of $255M-$330M in Investor Day presentation
- 08/08/22
- Castle Biosciences raises FY22 revenue view to $130M-$135M from $118M-$123M
- 11/29/22
- Crowdstrike raises FY23 EPS view to $1.49-$1.52 from $1.31-$1.33
- 11/29/22
- Crowdstrike sees Q4 adjusted EPS 42c-45c, consensus 34c
- 11/29/22
- Crowdstrike reports Q3 adjusted EPS 40c, consensus 31c
- 11/29/22
- Notable companies reporting after market close
- 12/06/22
- Avid Bioservices raises FY23 revenue view to $145M-$150M from $140M-$145M
- 12/06/22
- Avid Bioservices reports Q2 EPS (2c), consensus 0c
- 09/06/22
- Avid Bioservices reports Q1 EPS 2c vs. 10c last year
CASY Casey's General Stores - 12/06/22
- Casey's General Stores reports Q2 EPS $3.67, consensus $3.16
- 09/07/22
- Casey's General Stores reports Q1 EPS $4.09, consensus $3.37
- 11/03/22
- Black Knight reports Q3 adjusted EPS 56c, consensus 66c
- 08/04/22
- Black Knight reports Q2 adjusted EPS 65c, consensus 64c
- 12/07/22
- Academy Sports raises FY22 adjusted EPS view to $7.50-$7.40 from $6.75-$7.50
- 12/07/22
- Academy Sports reports Q3 adjusted EPS $1.69, consensus $1.59
- 12/06/22
- Notable companies reporting before tomorrow's open
- 07/09/22
- Time to buy Watsco after stock falls 20%, Barron's says
- 08/26/22
- Wendy's pulls lettuce following dozens of E. coli infections, Bloomberg says
- 08/26/22
- Wendy's pulls lettuce following dozens of E. coli infections, Bloomberg says
- 08/24/22
- Wendy's E. coli outbreak worsens, 100 people have become ill, NY Post reports
- 07/26/22
- Comcast approached Vizio about potential acquisition, Protocol says
- 10/21/22
- Cybereason taps JPMorgan to help find buyer, The Information says
- 07/26/22
- Crowdstrike speaking to Israeli companies about possible buyouts, Globes reports
- 07/23/22
- Academy Sports stock still a winner, Barron's says
- 10/20/22
- Fly Intel: Pre-market Movers
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
- 11/09/22
- Fly Intel: Pre-market Movers
- 08/24/22
- What You Missed On Wall Street This Morning
- 10/05/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/10/22
- Fly Intel: After-Hours Movers
- 12/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/29/22
- What You Missed On Wall Street On Thursday
- 09/29/22
- What You Missed On Wall Street This Morning
- 09/01/22
- What You Missed On Wall Street On Thursday
- 10/19/22
- Fly Intel: After-Hours Movers
- 08/22/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/12/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/22/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/19/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 10/04/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 07/12/22
- What You Missed On Wall Street On Tuesday
- 08/12/22
- Sell these stocks now, proven algorithm says
- 12/17/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/10/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/05/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/03/22
- Buy/Sell: Wall Street's top 10 stock calls this week
- 12/07/22
- Biotech Alert: Searches spiking for these stocks today
CASY Casey's General Stores - 12/06/22
- Fly Intel: After-Hours Movers
- 11/17/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/07/22
- What You Missed On Wall Street On Wednesday
- 12/07/22
- What You Missed On Wall Street This Morning
- 12/07/22
- Fly Intel: Pre-market Movers
- 09/07/22
- What You Missed On Wall Street On Wednesday
- 09/12/22
- Wendy's call buyer realizes 30% same-day gains
- 11/15/22
- Knight Transportation put volume heavy and directionally bearish
- 10/19/22
- Knight Transportation options imply 4.8% move in share price post-earnings
- 08/18/22
- Unusually active option classes on open August 18th
- 07/20/22
- Knight Transportation options imply 3.3% move in share price post-earnings
- 09/21/22
- Seventeen new option listings on September 21st
- 11/29/22
- CrowdStrike Holdings options imply 8.9% move in share price post-earnings
- 09/01/22
- Unusually active option classes on open September 1st
- 08/30/22
- CrowdStrike Holdings options imply 8.6% move in share price post-earnings
- 08/24/22
- Unusually active option classes on open August 24th
- 12/06/22
- Academy Sports and Outdoors put volume heavy and directionally bearish
|
|
Conference/Events
|
Meeting to be held in… Meeting to be held in Denver on December 12 hosted by Barrington. ShowHide Related Items >><< - 11/01/22
- ModivCare appoints L. Heath Sampson as CEO
- 08/02/22
- ModivCare CEO Greenleaf to leave company, Sampson named interim CEO
- 11/04/22 Barrington
- ModivCare price target lowered to $138 from $157 at Barrington
- 08/05/22 Barrington
- ModivCare price target raised to $157 from $155 at Barrington
- 08/02/22 Stephens
- ModivCare initiated with an Overweight at Stephens
- 05/06/22 Deutsche Bank
- ModivCare price target lowered to $130 from $150 at Deutsche Bank
- 11/03/22
- ModivCare raises FY22 revenue view to $2.45B-$2.475B from $2.375B-$2.4B
- 11/03/22
- ModivCare reports Q3 adjusted EPS $1.61, consensus $1.62
- 08/04/22
- ModivCare raises FY22 revenue view to $2.375B-$2.4B from $2.35B-$2.375B
- 08/04/22
- ModivCare reports Q2 adjusted EPS $1.99 vs. $2.14 a year ago
|
|
Conference/Events
|
Meeting to be held in… Meeting to be held in Denver on December 12 hosted by Barrington. ShowHide Related Items >><< - 11/01/22
- ModivCare appoints L. Heath Sampson as CEO
- 08/02/22
- ModivCare CEO Greenleaf to leave company, Sampson named interim CEO
- 11/04/22 Barrington
- ModivCare price target lowered to $138 from $157 at Barrington
- 08/05/22 Barrington
- ModivCare price target raised to $157 from $155 at Barrington
- 08/02/22 Stephens
- ModivCare initiated with an Overweight at Stephens
- 05/06/22 Deutsche Bank
- ModivCare price target lowered to $130 from $150 at Deutsche Bank
- 11/03/22
- ModivCare raises FY22 revenue view to $2.45B-$2.475B from $2.375B-$2.4B
- 11/03/22
- ModivCare reports Q3 adjusted EPS $1.61, consensus $1.62
- 08/04/22
- ModivCare raises FY22 revenue view to $2.375B-$2.4B from $2.35B-$2.375B
- 08/04/22
- ModivCare reports Q2 adjusted EPS $1.99 vs. $2.14 a year ago
|
|
On The Fly
| ShowHide Related Items >><< - $83.63 /
+14.08 (+20.24%) - 10/20/22
- Wix.com announces $300M share repurchase program
- 09/16/22
- Starboard Value discloses 9% stake in Wix.com
- 08/31/22
- Choice partners with Wix.com for ACH payments
- 11/07/22
- Werner expands logistics capabilities with acquisition of ReedTMS Logistics
- 11/02/22
- Werner sees 2022 capital expenditures $300M-$325M vs. prior $275M-$325M
- 10/03/22
- Werner signs definitive agreement on acquisition of FAB9
- 09/29/22
- Werner, Kodiak Robotics announce partnership
WBA Walgreens Boots Alliance - 11/07/22
- WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD
- 11/02/22
- Walgreens Boots Alliance agrees to pay $4.95B to settle opioid claims
- 11/02/22
- Walgreens to pay about $5B to resolve some opioid lawsuits with states, tribes
- 11/02/22
- Western Union enters renewed five-year agreement with Walgreens
- 10/20/22
- The Hanover estimates Q3 catastrophe losses $90M
- 11/07/22
- Spirit AeroSystems rises 13.1%
- 10/19/22
- Spirit AeroSystems enters MOU with Joramco for MRO services cooperation
- 09/21/22
- Spirit AeroSystems enters MOU with MAB to develop MRO services for 737 aircraft
- 09/20/22
- Spirit AeroSystems SEAS joint venture to open in October
- 09/20/22
- Schneider, Torc Robotics announce pilot for autonomous test fleet
- 06/07/22
- Schneider National acquires Wisconsin-based carrier deBoer Transportation
- 11/03/22
- Cathie Wood's ARK Investment bought 116.4K shares of Roku today
- 11/03/22
- Roku CFO Steve Louden to step down in summer of 2023
- 11/02/22
- Cathie Wood's ARK Investment bought 43K shares of Roku today
- 11/02/22
- Roku down 18% after Q4 guidance miss
- 08/15/22
- Outset Medical awarded national contract from SAC for Tablo Hemodialysis System
- 08/01/22
- Outset Medical trading resumes
- 08/01/22
- Outset Medical announces resumption of Tablo shipments for home use
- 08/01/22
- Outset Medical trading halted, news pending
- $387.08 /
+42.73 (+12.41%) - 05/25/22
- Monolithic launches MPSafe Portfolio of safety-oriented automotive products
- 10/10/22
- Light & Wonder names Matt Wilson CEO
- 10/06/22
- Light & Wonder acquires House Advantage assets in cash transaction
- 10/04/22
- Engine Capital calls on Light & Wonder to acquire remaining stake in SciPlay
- 07/06/22
- Light & Wonder announces agreement between OpenBet, Sazkabet
- 11/10/22
- Jounce Therapeutics expects cash to fund operating expenses into 1Q24
- 11/02/22
- Jounce earns clinical milestone payment under agreement with Gilead
- 10/20/22
- Jounce Therapeutics to present multiple posters at SITC annual meeting
- 08/30/22
- Jounce Therapeutics reports results from Phase 2 SELECT trial
- 10/27/22
- Intel reports Q3 Mobileye revenue $450M
- 10/27/22
- Intel focused on driving $3B in cost reductions in 2023
- 10/27/22
- Intel sees FY22 gross margin 47.5%, tax rate 2%
- 10/19/22
- Intel announces new cloud collaboration with HashiCorp
- 08/22/22
- TFI International to sell CFI's truckload business to Heartland for $525M
- 08/22/22
- Heartland Express to acquire Contract Freighters truckload business for $525M
- 06/01/22
- Heartland Express acquires Smith Transport, related companies, for $170M
- 05/12/22
- Expensify authorizes up to $50M share buyback program
- 11/10/22
- EQRx expecst cash to fund operations into 2028
- 08/11/22
- EQRx expects cash to fund operations at least into 2025
- 08/07/22
- EQRx announces updated data from Phase 3 trial of Sugemalimab
- 06/14/22
- EQRx announces acceptance of MAA by the UK's MHRA for aumolertinib
- 10/18/22
- Coherent appoints Julie Sheridan Eng as Chief Technology Officer
- 10/17/22
- Windstream partners with Coherent, Nokia for 400 Gig networking
- 09/16/22
- Coherent introduces ultrahigh-resolution telemetry module
- 09/15/22
- Coherent introduces 200G indium phosphide EMLs for datacenter transceivers
- 11/11/22
- Air Lease announces long-term lease placements for three new Boeing aircraft
- 11/10/22
- U.S. watchdog initiates audit into FAA's oversight of Boeing MAX features
- 11/10/22
- Alaska Air Cargo selects Boeing to convert 2 passenger aircraft to freighters
- 11/10/22
- Boeing, Silk Way West Airlines announce order for 777-8 Freighters
WBA Walgreens Boots Alliance - 11/11/22 Deutsche Bank
- Walgreens upgraded to Buy with $50 target at Deutsche Bank
- 11/11/22 Deutsche Bank
- Walgreens Boots Alliance upgraded to Buy from Hold at Deutsche Bank
- 11/08/22 Truist
- Walgreens Boots Alliance price target raised to $44 from $38 at Truist
- 10/25/22 Deutsche Bank
- Walgreens Boots Alliance price target raised to $41 from $38 at Deutsche Bank
- 11/11/22 UBS
- UBS upgrades Werner, Schneider National, Heartland Express to Buy
- 11/11/22 UBS
- Werner upgraded to Buy from Neutral at UBS
- 11/07/22 Deutsche Bank
- Werner price target lowered to $48 from $54 at Deutsche Bank
- 10/14/22 Vertical Research
- Werner downgraded to Hold from Buy at Vertical Research
- 11/11/22 UBS
- Schneider National upgraded to Buy from Neutral at UBS
- 10/07/22 Citi
- Schneider National price target lowered to $24 from $26 at Citi
- 10/05/22 Stifel
- Schneider National target trimmed to $29, named top pick in Trucking at Stifel
- 11/11/22 UBS
- Heartland Express upgraded to Buy from Neutral at UBS
- 10/11/22 Barclays
- Heartland Express price target lowered to $13 from $14 at Barclays
- 08/23/22 Baird
- Heartland Express price target raised to $17 from $14 at Baird
- 11/11/22 BofA
- Coherent upgraded to Buy at BofA on diversity, valuation
- 11/11/22 BofA
- Coherent upgraded to Buy from Neutral at BofA
- 11/10/22 Craig-Hallum
- Coherent price target raised to $60 from $50 at Craig-Hallum
- 11/10/22 Cowen
- Coherent price target lowered to $95 from $116 at Cowen
- 11/11/22 Deutsche Bank
- Light & Wonder price target raised to $52 from $48 at Deutsche Bank
- 11/11/22 Macquarie
- Light & Wonder resumed with Outperform from Neutral at Macquarie
- 10/04/22 Truist
- Truist says has raised similar points on SciPlay as Engine Capital
- 08/10/22 Craig-Hallum
- Light & Wonder price target lowered to $90 from $105 at Craig-Hallum
- 11/11/22 BofA
- BofA double downgrades '737 story' Spirit AeroSystems to Underperform
- 11/11/22 BofA
- Spirit AeroSystems downgraded to Underperform from Buy at BofA
- 11/07/22 Wolfe Research
- Spirit AeroSystems upgraded to Peer Perform from Underperform at Wolfe Research
- 11/04/22 Truist
- Spirit AeroSystems price target lowered to $39 from $46 at Truist
- 11/07/22 Redburn
- Boeing initiated with a Neutral at Redburn
- 11/03/22 Morgan Stanley
- Morgan Stanley says Boeing clarity 'eases some burden,' execution to be catalyst
- 11/03/22 BofA
- BofA keeps Neutral rating on Boeing after 'one of most frank conferences'
- 11/11/22 Goldman Sachs
- EQRx downgraded to Neutral from Buy at Goldman Sachs
- 11/11/22 Jefferies
- Jefferies downgrades 'frustrating' EQRx to Hold
- 11/11/22 Jefferies
- EQRx downgraded to Hold from Buy at Jefferies
- 08/16/22 JPMorgan
- JPMorgan starts EQRx at Neutral amid 'number of unknowns'
- $83.63 /
+14.08 (+20.24%) - 11/11/22 Needham
- Wix.com price target raised to $100 from $85 at Needham
- 11/11/22 JPMorgan
- Wix.com initiated with a Neutral at JPMorgan
- 11/11/22 Citi
- Wix.com price target raised to $101 from $91 at Citi
- 10/19/22 Morgan Stanley
- Wix.com price target lowered to $81 from $89 at Morgan Stanley
- 11/11/22 Jefferies
- Jefferies starts Roku at Hold amid uncertainty for ad market
- 11/11/22 Jefferies
- Roku initiated with a Hold at Jefferies
- 11/04/22 Citi
- Roku price target lowered to $80 from $125 at Citi
- 11/04/22 Cannonball Research
- Roku downgraded to Neutral from Buy at Cannonball Research
- 11/11/22 Janney Montgomery Scott
- Janney starts The Hanover with a Buy, $164 fair value estimate
- 11/11/22 Janney Montgomery Scott
- The Hanover initiated with a Buy at Janney Montgomery Scott
- 11/07/22 Piper Sandler
- The Hanover downgraded to Neutral from Overweight at Piper Sandler
- 06/29/22 Morgan Stanley
- The Hanover initiated with an Equal Weight at Morgan Stanley
- 11/11/22 RBC Capital
- Outset Medical initiated with an Outperform at RBC Capital
- 11/09/22 Cowen
- Outset Medical price target lowered to $22 from $33 at Cowen
- 08/02/22 Morgan Stanley
- Outset Medical remains 'a show-me story,' says Morgan Stanley
- 07/18/22 Stifel
- Outset Medical price target lowered to $24 from $30 at Stifel
BXSL Blackstone Secured Lending Fund - 11/11/22 Janney Montgomery Scott
- Janney upgrades Blackstone Secured to Buy, sees 23% total return
- 11/11/22 Janney Montgomery Scott
- Blackstone Secured Lending upgraded to Buy from Neutral at Janney Montgomery
- 07/12/22 Compass Point
- Blackstone Secured Lending Fund upgraded to Buy at Compass Point
- 07/12/22 Compass Point
- Blackstone Secured upgraded to Buy from Neutral at Compass Point
- 11/11/22 JPMorgan
- Intel resumed with Underweight from Overweight at JPMorgan
- 11/02/22 Stifel
- AMD price target lowered to $91 from $100 at Stifel
- 11/02/22 UBS
- AMD price target lowered to $75 from $80 at UBS
- 10/31/22 Citi
- Intel price target lowered to $27 from $30 at Citi
- $387.08 /
+42.73 (+12.41%) - 11/11/22 Wells Fargo
- Monolithic Power initiated with an Overweight at Wells Fargo
- 11/01/22 Craig-Hallum
- Lattice Semiconductor price target lowered to $50 from $58 at Craig-Hallum
- 10/28/22 Cowen
- Monolithic Power price target lowered to $425 from $600 at Cowen
- 10/28/22 Deutsche Bank
- Monolithic Power price target lowered to $400 from $410 at Deutsche Bank
- 11/11/22 Piper Sandler
- Expensify downgraded to Neutral from Overweight at Piper Sandler
- 10/21/22 Citi
- Expensify price target lowered to $20 from $25 at Citi
- 10/20/22 Piper Sandler
- Expensify price target lowered to $18 from $26 at Piper Sandler
- 09/01/22 Citi
- Expensify assumed with a Buy at Citi
- 11/11/22 Raymond James
- Raymond James downgrades Jounce to Outperform on ILT inhibitor data
- 11/10/22 Raymond James
- Jounce Therapeutics downgraded to Outperform from Strong Buy at Raymond James
- 08/30/22 Piper Sandler
- Jounce Therapeutics price target lowered to $6 from $9 at Piper Sandler
- 08/05/22 H.C. Wainwright
- Jounce Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
- $83.63 /
+14.08 (+20.24%) - 11/10/22
- Wix.com sees FY22 revenue up 9%, consensus $1.38B
- 11/10/22
- Wix.com sees Q4 revenue $349M-$354M, consensus $351.15M.
- 11/10/22
- Wix.com reports Q3 EPS 6c, consensus (9c)
- 08/10/22
- Wix.com reports Q2 EPS (14c) vs. (28c) last year
- 11/02/22
- Werner reports Q3 adjusted EPS 90c, consensus 97c
- 08/03/22
- Werner reports Q2 EPS 87c, consensus $1.03
WBA Walgreens Boots Alliance - 10/13/22
- Walgreens Boots Alliance sees FY23 adjusted EPS $4.45-$4.65, consensus $5.01
- 10/13/22
- Walgreens Boots Alliance reports Q4 adjusted EPS 80c, consensus 77c
- 10/12/22
- Notable companies reporting before tomorrow's open
- 06/30/22
- Walgreens Boots Alliance backs FY22 EPS outlook of low single digit growth
- 11/01/22
- The Hanover reports Q3 EPS 99c, consensus 97c
- 10/20/22
- The Hanover sees Q3 operating EPS 95c-$1.00, consensus $1.35
- 08/02/22
- The Hanover reports Q2 EPS $2.32, consensus $2.16
- 11/03/22
- Spirit AeroSystems reports Q3 EPS (15c), consensus (40c)
- 11/02/22
- Notable companies reporting before tomorrow's open
- 08/03/22
- Spirit AeroSystems reports Q2 adjusted EPS ($1.21), consensus (24c)
- 10/27/22
- Schneider National narrows FY22 adj. EPS view to $2.60-$2.65 from $2.60-$2.70
- 10/27/22
- Schneider National reports Q3 adjusted EPS 70c, consensus 68c
- 07/28/22
- Schneider National raises FY22 adjusted EPS view to $2.60-$2.70 from $2.55-$2.70
- 07/28/22
- Schneider National reports Q2 adjusted EPS 72c, consensus 69c
- 11/02/22
- Roku sees Q4 revenue $800M, consensus $895.22M
- 11/02/22
- Roku reports Q3 EPS (88c), consensus ($1.28)
- 11/02/22
- Notable companies reporting after market close
- 07/28/22
- Roku sees Q3 revenue roughly $700M, consensus $901.73M
- 11/08/22
- Outset Medical raises FY22 revenue view to $111M-$113M from $105M-$110M
- 11/08/22
- Outset Medical reports Q3 EPS (70c), consensus (81c)
- 08/01/22
- Outset Medical sees 2022 revenue $105M-$110M, consensus $127.88M
- 08/01/22
- Outset Medical reports Q2 EPS (77c), consensus (70c)
- $387.08 /
+42.73 (+12.41%) - 10/27/22
- Monolithic Power sees Q4 revenue $450M-$470M, consensus $486.08M
- 10/27/22
- Monolithic Power reports Q3 diluted EPS $3.53, consensus $3.50
- 08/01/22
- Monolithic Power sees Q3 revenue $480M-$500M, consensus $466.06M
- 08/01/22
- Monolithic Power reports Q2 EPS $3.25, consensus $2.94
- 11/09/22
- Light & Wonder reports Q3 EPS 14c, consensus 39c
- 08/09/22
- Light & Wonder reports Q2 EPS $34.61 vs $1.13 last year
- 11/10/22
- Jounce Therapeutics reports Q3 EPS (60c), consensus (64c)
- 08/04/22
- Jounce Therapeutics reports Q2 EPS (65c), consensus (68c)
- 10/27/22
- Intel sees Q4 adjusted EPS 20c, consensus 66c
- 10/27/22
- Intel cuts FY22 adjusted EPS view to $1.95 from $2.30
- 10/27/22
- Intel cuts FY revenue view to $63B-$64B from $65B-$68B
- 10/27/22
- Intel reports Q3 adjusted EPS 59c, consensus 32c
- 11/02/22
- Heartland Express reports Q3 EPS 31c, consensus 30c
- 07/25/22
- Heartland Express reports Q2 EPS 97c, consensus 25c
- 11/10/22
- Expensify reports Q3 EPS (10c), consensus 8c
- 08/11/22
- Expensify reports Q2 EPS (10c), consensus 9c
- 05/12/22
- Expensify backs long-term revenue growth view of 25%-35%
- 05/12/22
- Expensify reports Q1 EPS (9c), consensus 5c
- 11/10/22
- EQRx reports Q3 EPS (18c) vs (12c) last year
- 08/11/22
- EQRx reports Q2 EPS (17c), cosensus (19c)
- 05/13/22
- EQRx reports Q1 EPS 4c vs. (9c) last year
- 11/09/22
- Coherent sees FY23 revenue $5.25B-$5.55B, consensus $5.43B
- 11/09/22
- Coherent sees Q2 adjusted EPS 88c-$1.00, consensus 94c
- 11/09/22
- Coherent reports Q1 adjusted EPS $1.04, consensus 83c
- 05/11/22
- Coherent reports Q2 adjusted EPS $1.70, consensus $2.28
- 10/26/22
- Boeing reports Q3 core EPS ($6.18), consensus 2c
- 10/25/22
- Notable companies reporting before tomorrow's open
- 07/27/22
- Boeing reports Q2 core EPS (37c), consensus (16c)
- $83.63 /
+14.08 (+20.24%) - 09/16/22
- Starboard amasses roughly 9% stake in Wix.com, Reuters reports
WBA Walgreens Boots Alliance - 11/07/22
- Walgreens-backed VillageMD close to $9B deal with Summit, WSJ reports
- 11/01/22
- Walgreens, Walmart, CVS reach $12B opioid settlement deal, Bloomberg reports
- 11/01/22
- Walgreens-backed VillageMD in talks to merge with Summit, Bloomberg reports
- 10/02/22
- Walgreens turns to prescription-filling robots to free up pharmacists, WSJ says
- 09/15/22
- Roku's 'curious' change in control plan 'worth closer look,' Dealreporter says
- 06/14/22
- Netflix talked with Roku, Comcast about ad sales, The Information reports
- 06/08/22
- Roku staff 'buzzing' about possibility of being bought by Netflix, Insider says
- 10/27/22
- VW to expand automated driving partnership with Mobileye, Reuters says
- 10/25/22
- Intel CEO says new U.S. semiconductor restrictions inevitable, WSJ reports
- 10/24/22
- Mobileye Global set to price shares at top end or above range, WSJ reports
- 10/18/22
- Intel is looking at much lower valuation in IPO of Mobileye unit, WSJ reports
- 06/23/22
- China to conditionally clear II-VI deal to buy Coherent, Dealreporter says
- 05/18/22
- II-VI, Coherent see uncertainty added to SAMR deal reviews, Capitol Forum says
- 10/30/22
- China Southern cancels planned return of Boeing 737 MAX flights, Reuters says
- 10/24/22
- New Vista in talks to take Flair Airlines public, Bloomberg reports
- 10/23/22
- Judge says Boeing 737 MAX criminal settlement can be challenged, WSJ reports
- 10/18/22
- Boeing offers 737 Max jets to Air India, Bloomberg reports
- $83.63 /
+14.08 (+20.24%) - 09/29/22
- What You Missed On Wall Street On Thursday
- 09/29/22
- What You Missed On Wall Street This Morning
- 09/29/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
WBA Walgreens Boots Alliance - 11/11/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/11/22
- Fly Intel: Pre-market Movers
- 11/07/22
- What You Missed On Wall Street On Monday
- 11/07/22
- What You Missed On Wall Street This Morning
- 09/08/22
- What You Missed On Wall Street On Thursday
- 09/08/22
- What You Missed On Wall Street This Morning
- 09/08/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 09/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/22/22
- What You Missed On Wall Street On Monday
- 08/22/22
- What You Missed On Wall Street This Morning
- 11/03/22
- What You Missed On Wall Street On Thursday
- 11/03/22
- What You Missed On Wall Street This Morning
- 11/03/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/01/22
- What You Missed On Wall Street On Monday
- 08/01/22
- What You Missed On Wall Street This Morning
- 06/14/22
- What You Missed On Wall Street On Tuesday
- $387.08 /
+42.73 (+12.41%) - 10/27/22
- Fly Intel: After-Hours Movers
- 08/01/22
- Fly Intel: After-Hours Movers
- 10/29/22
- Opening Day: Intel's Mobileye jumps in market return
- 10/28/22
- What You Missed On Wall Street On Friday
- 07/25/22
- What You Missed On Wall Street On Monday
- 07/25/22
- What You Missed On Wall Street This Morning
- 11/10/22
- Fly Intel: After-Hours Movers
- 08/11/22
- Fly Intel: After-Hours Movers
- 07/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 08/16/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/09/22
- What You Missed On Wall Street On Wednesday
- 11/09/22
- What You Missed On Wall Street This Morning
- 06/28/22
- What You Missed On Wall Street On Tuesday
- 11/07/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/02/22
- What You Missed On Wall Street On Wednesday
- 11/02/22
- What You Missed On Wall Street This Morning
- $83.63 /
+14.08 (+20.24%) - 10/12/22
- Largest borrow rate increases among liquid names
WBA Walgreens Boots Alliance - 11/07/22
- Early notable gainers among liquid option names on November 7th
- 11/07/22
- Unusually active option classes on open November 7th
- 10/13/22
- Early notable gainers among liquid option names on October 13th
- 10/13/22
- Unusually active option classes on open October 13th
- 11/04/22
- Unusually active option classes on open November 4th
- 11/02/22
- Roku options imply 15.8% move in share price post-earnings
- 09/26/22
- Roku call volume above normal and directionally bullish
- 09/19/22
- Unusually active option classes on open September 19th
- $387.08 /
+42.73 (+12.41%) - 08/02/22
- Early notable gainers among liquid option names on August 2nd
- 10/28/22
- Early notable gainers among liquid option names on October 28th
- 10/28/22
- Notable open interest changes for October 28th
- 10/27/22
- Intel options imply 7.4% move in share price post-earnings
- 10/24/22
- Intel call buyer realizes 10% same-day gains
- 09/08/22
- Four new option listings and two option delistings on September 8th
- 07/05/22
- Two new option listings and three option delistings on July 5th
BXSL Blackstone Secured Lending Fund - 10/19/22
- Twelve new option listings and two option delistings on October 19th
- 11/03/22
- Boeing call volume above normal and directionally bullish
- 10/28/22
- Unusually active option classes on open October 28th
- 10/26/22
- Unusually active option classes on open October 26th
- 10/11/22
- Unusually active option classes on open October 11th
|
|
Initiation
|
RBC Capital analyst… RBC Capital analyst Shagun Singh initiated coverage of Outset Medical with an Outperform rating and $23 price target. The stock is significantly undervalued given the opportunities with its first-of-its-kind technology designed to reduce cost and complexity of dialysis in a $11B U.S. market for the treatment of kidney failure, the analyst tells investors in a research note. Outset is poised to deliver 3-year and 5-year revenue CAGRs of 46% and 39%, which is among the highest in MedTech, Singh adds. ShowHide Related Items >><< - 08/15/22
- Outset Medical awarded national contract from SAC for Tablo Hemodialysis System
- 08/01/22
- Outset Medical trading resumes
- 08/01/22
- Outset Medical announces resumption of Tablo shipments for home use
- 08/01/22
- Outset Medical trading halted, news pending
- 11/09/22 Cowen
- Outset Medical price target lowered to $22 from $33 at Cowen
- 08/02/22 Morgan Stanley
- Outset Medical remains 'a show-me story,' says Morgan Stanley
- 07/18/22 Stifel
- Outset Medical price target lowered to $24 from $30 at Stifel
- 07/14/22 Morgan Stanley
- Outset Medical downgraded to Equal Weight from Overweight at Morgan Stanley
- 11/08/22
- Outset Medical raises FY22 revenue view to $111M-$113M from $105M-$110M
- 11/08/22
- Outset Medical reports Q3 EPS (70c), consensus (81c)
- 08/01/22
- Outset Medical sees 2022 revenue $105M-$110M, consensus $127.88M
- 08/01/22
- Outset Medical reports Q2 EPS (77c), consensus (70c)
- 08/01/22
- What You Missed On Wall Street On Monday
- 08/01/22
- What You Missed On Wall Street This Morning
- 06/14/22
- What You Missed On Wall Street On Tuesday
- 06/14/22
- What You Missed On Wall Street This Morning
|
|
Recommendations
|
Cowen analyst Joshua… Cowen analyst Joshua Jennings lowered the firm's price target on Outset Medical to $22 from $33 and keeps an Outperform rating on the shares. The analyst said while they noted persistent macro challenges for its customers, it still raised its 2022 revenue guidance. ShowHide Related Items >><< - 08/15/22
- Outset Medical awarded national contract from SAC for Tablo Hemodialysis System
- 08/01/22
- Outset Medical trading resumes
- 08/01/22
- Outset Medical announces resumption of Tablo shipments for home use
- 08/01/22
- Outset Medical trading halted, news pending
- 08/02/22 Morgan Stanley
- Outset Medical remains 'a show-me story,' says Morgan Stanley
- 07/18/22 Stifel
- Outset Medical price target lowered to $24 from $30 at Stifel
- 07/14/22 Morgan Stanley
- Outset Medical downgraded to Equal Weight from Overweight at Morgan Stanley
- 06/14/22 Cowen
- Outset Medical price target lowered to $33 from $60 at Cowen
- 11/08/22
- Outset Medical raises FY22 revenue view to $111M-$113M from $105M-$110M
- 11/08/22
- Outset Medical reports Q3 EPS (70c), consensus (81c)
- 08/01/22
- Outset Medical sees 2022 revenue $105M-$110M, consensus $127.88M
- 08/01/22
- Outset Medical reports Q2 EPS (77c), consensus (70c)
- 08/01/22
- What You Missed On Wall Street On Monday
- 08/01/22
- What You Missed On Wall Street This Morning
- 06/14/22
- What You Missed On Wall Street On Tuesday
- 06/14/22
- What You Missed On Wall Street This Morning
|
|
Earnings
| ShowHide Related Items >><< - 08/15/22
- Outset Medical awarded national contract from SAC for Tablo Hemodialysis System
- 08/01/22
- Outset Medical trading resumes
- 08/01/22
- Outset Medical announces resumption of Tablo shipments for home use
- 08/01/22
- Outset Medical trading halted, news pending
- 08/02/22 Morgan Stanley
- Outset Medical remains 'a show-me story,' says Morgan Stanley
- 07/18/22 Stifel
- Outset Medical price target lowered to $24 from $30 at Stifel
- 07/14/22 Morgan Stanley
- Outset Medical downgraded to Equal Weight from Overweight at Morgan Stanley
- 06/14/22 Cowen
- Outset Medical price target lowered to $33 from $60 at Cowen
- 11/08/22
- Outset Medical reports Q3 EPS (70c), consensus (81c)
- 08/01/22
- Outset Medical sees 2022 revenue $105M-$110M, consensus $127.88M
- 08/01/22
- Outset Medical reports Q2 EPS (77c), consensus (70c)
- 06/13/22
- Outset Medical sees Q2 revenue 'at least' $25M, suspends FY22 guidance
- 08/01/22
- What You Missed On Wall Street On Monday
- 08/01/22
- What You Missed On Wall Street This Morning
- 06/14/22
- What You Missed On Wall Street On Tuesday
- 06/14/22
- What You Missed On Wall Street This Morning
|
